Ronald Oudiz, MD, FACP, FACC, FCCP, Professor of Medicine, Director, Pulmonary Hypertension Clinic, Chief, Division of Cardiology, Harbor-UCLA Medical Center, discusses pulmonary arterial hypertension (PAH) and ways to engage with care teams for increased compliance and adherence.

Pulmonary arterial hypertension (PAH) affects the heart and lungs and is characterized by abnormally high blood pressure (hypertension) in the pulmonary artery, the blood vessel that carries blood from the heart to the lungs. Symptoms include shortness of breath (dyspnea) during exercise and fainting spells. The symptoms tend to get worse over time and may include dizziness, swelling (edema) of the ankles or legs, chest pain, and a racing pulse. Some cases of PAH are due to genetic changes in the BMPR2 gene and inherited in an autosomal dominant pattern. Diagnosis is based on the symptoms, clinical examination, and specialized testing.

For more information on PAH, visit the National Center for Advancing Translational Sciences webpage on pulmonary arterial hypertension: https://rarediseases.info.nih.gov/dis… 

 

This content is supported by Bayer. This page was developed by CheckRare, and the supporter did not influence the final article or editorial themes of this content.